We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Provider of VNAs for Oncology Sites Reaches Significant Milestone

By MedImaging International staff writers
Posted on 26 Sep 2016
Image: The Synapse VNA is provides medical image and information management for enterprises (Photo courtesy of FUJIFILM).
Image: The Synapse VNA is provides medical image and information management for enterprises (Photo courtesy of FUJIFILM).
A large diagnostic imaging products and medical informatics solutions provider has announced that they have reached a milestone in the number of installations of their enterprise-wide medical information and image management Vendor Neutral Archive (VNA).

The company has installed more than 300 of the scalable VNA storage systems, used for managing cancer treatment data, at oncology sites around the world. The VNA manages all DICOM (Digital Imaging and Communications in Medicine) and non-DICOM clinical oncology department data, used in the treatment of cancer patients. The data includes radiology diagnostic images, radiation treatment plans, and other clinical data. The oncology facilities that use the Synapse VNA interface more than 800 linear accelerators (linacs).

FUJIFILM Medical Systems U.S.A. (Stamford, CT, USA) developed the Synapse VNA technology interface. The company is also a leading worldwide provider of diagnostic imaging products, and medical informatics solutions, including digital X-Ray systems, Radiology Information Systems (RIS), the Synapse PACS (Picture Archiving and Communication System), cardiovascular products, and advanced imaging systems for the women’s health market. The Synapse VNA enables clinicians to access and securely share the data and back it up, with disaster recovery capabilities.

VP of FUJIFILM Medical Systems TeraMedica Division USA, Greg Strowig, said, “Fujifilm truly dominates the oncology VNA space both for our innovative technology and also our knowledge of what it takes to deliver better cancer care. Cancer centers across the globe have turned to us because of our unparalleled experience with the management of cancer treatment data.”

Related Links:
FUJIFILM Medical Systems U.S.A.

Ultrasound Needle Guidance System
SonoSite L25
X-ray Diagnostic System
FDX Visionary-A
Half Apron
Demi
Adjustable Mobile Barrier
M-458

Channels

General/Advanced Imaging

view channel
Image: The study developed a marker based on the analysis of routine CT scans of gastric cancer patients treated at UNICAMP. Higher radiodensity values for adipose tissue are linked to a worse prognosis. In contrast, higher values for muscle are linked to a more favorable outcome (Photo courtesy of FCM-UNICAMP)

CT-Derived Biomarker Predicts Outcomes in Gastric Cancer

Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.